The Reed-Sternberg cell in classical Hodgkin's disease

Hematological Oncology

Volumn 19, Issue 1, 2001, Pages 1-17

  Chan, Wing C ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN HEAVY CHAIN;

B LYMPHOCYTE; CARCINOGENESIS; CELL INTERACTION; CELL LINEAGE; CYTOGENETICS; CYTOKINE RELEASE; EPSTEIN BARR VIRUS; GENE EXPRESSION; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LYMPHOCYTE CLONE; PLOIDY; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; T LYMPHOCYTE; TH2 CELL;

CLONE CELLS; CYTOGENETIC ANALYSIS; CYTOKINES; HODGKIN DISEASE; HUMANS; REED-STERNBERG CELLS;

EID: 0035061593     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.659     Document Type: Review

References (142)

1. On some morbid appearances of the absorbent glands and spleen
2. Hodgkin's disease. II. Pathology
3. The pathology and nomenclature of Hodgkin's disease
4. The natural history, histopathology, staging, and mode of spread of Hodgkin's disease
5. Hodgkin's disease: Unfolding concepts concerning its nature, management and prognosis
6. Hodgkin's disease: Biology, treatment, prognosis
7. World Health Organization Classification of lymphomas: A work in progress
8. Cytogenetic studies in untreated Hodgkin's disease
9. Chromosomal abnormalities in Hodgkin's disease
10. Clonal cytogenetic abnormalities in Hodgkin's disease
11. Determination of the DNA content of the Reed-Sternberg cell of Hodgkin's disease by image analysis
12. The Reed-Sternberg cells of Hodgkin disease are clonal
13. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease
14. Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed-Sternberg cells
15. Technical aspects of lymphoma immunohistology
16. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells?
17. Immunophenotype of Reed-Sternberg cells
18. Cellular origin of nodular lymphocytic predominance Hodgkin's lymphoma: Immunophenotypic and molecular studies
19. Hodgkin's disease, lymphocyte predominance type, nodular - Further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker
20. Immunophenotypes of Reed-Sternberg cells: A study of 19 cases of Hodgkin's disease in plastic-embedded sections
21. Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies
22. The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues
23. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1
24. Expression of T-cell-receptor beta chain in Reed-Sternberg cells
25. The arrangement of immunoglobulin and T cell receptor genes in human lymphoproliferative disorders
26. Gene analysis and Epstein-Barr viral genome studies of Hodgkin's disease
27. Rearranged antigen receptor genes in Hodgkin's disease
28. Immunoglobulin gene rearrangements in Hodgkin's disease
29. Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease
30. Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin's disease: Implications for lineage determination and differential diagnosis
31. Clonal rearrangements of T-cell receptor and immunoglobulin genes and immunophenotypic antigen expression in different subclasses of Hodgkin's disease
32. Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease
33. Polyclonal rearrangement of the T-cell antigen receptor genes in Hodgkin's disease: Implications for diagnosis
34. Limited diversity and selection of rearranged gamma genes in polyclonal T cells
35. Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes
36. Molecular analysis of the IgH gene in 212 cases of Hodgkin's disease: Correlation of IgH clonality with the histologic and the immunocytochemical features
37. Clonal VDJ recombination of the immunoglobulin heavy chain gene by PCR in classical Hodgkin's disease
38. Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease
39. Epidemiology of Hodgkin's disease in the young
40. Childhood social environment and Hodgkin's disease
41. Hodgkin's disease in patients with previous infectious mononucleosis: 30 Years' experience
42. Infectious mononucleosis and Hodgkin's disease
43. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis
44. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease
45. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization
46. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease
47. Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells
48. Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonality
49. High incidence of Epstein-Barr virus genomes in Hodgkin's disease
50. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease
51. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections
52. Hodgkin's disease and Epstein-Barr virus
53. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
54. Epstein-Barr viral DNA in tissues of Hodgkin's disease
55. Epstein-Barr virus in Hodgkin's disease
56. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru
57. Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy
58. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease
59. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development
60. Lymphocyte predominance Hodgkin's disease: Lineage and clonality determination using a single-cell assay
61. Detection of immunoglobulin heavy-chain gene rearrangement at the single-cell level in malignant lymphomas: No rearrangement is found in Hodgkin and Reed-Sternberg cells
62. Micromanipulation and PCR analysis of single cells from tissue sections
63. Molecular studies on single cells harvested by micromanipulation from archival tissue sections previously stained by immunohistochemistry or nonisotopic in situ hybridization
64. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells
65. Phenotype, genotype and clonality of Reed-Sternberg cells in nodular sclerosis Hodgkin's disease: Results of a single-cell study
66. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells
67. Immunoglobulin V genes in Reed-Sternberg cells
68. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription
69. Hodgkin and Reed-Sternberg cells do not carry T-cell receptor gamma gene rearrangements: Evidence from single-cell polymerase chain reaction examination
70. Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with 'Hodgkin's transformation'
71. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma
72. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies
73. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
74. Mutations of p53 gene and their relation to disease progression in B- cell lymphoma
75. p53 mutations are associated with histologic transformation of follicular lymphoma
76. p53 mutation is associated with progression in follicular lymphomas
77. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis
78. PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease
79. P53 as a marker of the malignant cell in Hodgkin's disease
80. P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease
81. p53 mutations in Hodgkin's disease
82. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression
83. Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease
84. MDM2 and p21 WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease
85. Expression of p53 and mdm-2 proteins in Hodgkin's disease. Absence of correlation with the presence of Epstein-Barr virus
86. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease
87. Amplification of the MDM2 and lack of mutations of the p53 gene in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: Results from single cell polymerase chain reaction and molecular cytogenetic studies
88. Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations
89. A study of p53 protein, proliferating cell nuclear antigen, and p21 in Hodgkin's disease at presentation and relapse
90. Involvement of the bcl-2 gene in Hodgkin's disease
91. Direct sequence analysis of the t(14;18) chromosomal translocation in Hodgkin's disease
92. The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction
93. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma
94. Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes
95. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus
96. Chromosomal abnormalities in patients with Hodgkin's disease: Evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed-Sternberg cells
97. Bcl-2 oncogene protein is preferentially expressed in Reed-Sternberg cells in Hodgkin's disease of the nodular sclerosis subtype
98. An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease
99. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus
100. Hodgkin cells accumulate mRNA for bcl-2
101. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease
102. Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease
103. Immunohistochemical analysis of interleukin-1 beta-converting enzyme/Ced-3 family protease, CPP32/Yama/Caspase-3, in Hodgkin's disease
104. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
105. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
106. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells
107. Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma
108. CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
109. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease
110. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines
111. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line
112. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues
113. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis
114. CD40 expression in Hodgkin's disease
115. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines
116. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines
117. In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease
118. Hodgkin's disease: A tumor with disturbed immunological pathways
119. Immune escape mechanisms in Hodgkin's disease
120. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltration Hodgkin's lymphoma
121. CD95 ligand is expressed in Reed-Sternberg cells of Hodgkin's disease
122. Autocrine and paracrine functions of cytokines in malignant lymphomas
123. Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease
124. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease
125. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study
126. Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases
127. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia
128. Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma
129. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease
130. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells
131. Human and viral interleukin-10 in Hodgkin's disease, and its influence on CD4+ and CD8+ T lymphocytes
132. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease
133. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease
134. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells
135. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils
136. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease
137. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease
138. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease
139. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30 + anaplastic large cell lymphomas
140. Expression of p55 (Tac) interleukin-2 receptor (IL-2R), but not p75 IL-2R, in cultured H-RS cells and H-RS cells in tissues
141. Gene expression by single Reed-Sternberg cells: Pathways of apoptosis and activation
142. Reed-Sternberg cell genome expression supports a B-cell lineage